The directions of transformation of the state industrial policy in the Russian pharmaceutical industry in the conditions of import substitution
The modern model of development of the Russian economy is formed on the basis of the technological basis of the next industrial revolution, which leads not only to the onset of the sixth technological order, but also to a change in the current innovation and industrial paradigm. Under these conditions, an active state industrial policy should play a dominant role in the implementation of progressive structural changes in the economy. At the same time, consideration of issues of state support for industry and structural changes in the economy should have a pronounced sectoral character. Due to the fact that the pharmaceutical industry is one of the fastest growing and highly profitable segments of the world and domestic industry, a comprehensive study of the strategic management of the domestic pharmaceutical industry is extremely relevant in modern conditions. This is explained, first of all, by the fact that the pharmaceutical industry is the most important component of the national security strategy of the state due to the high social importance of this sphere and the current geopolitical situation. In the present article, based on the analysis of the current state of the pharmaceutical industry, the main directions of its development are determined. Identified and systematized the main problems that are of most concern to domestic and foreign companies in the industry, and identified areas of state regulation of the pharmaceutical industry, requiring improvement. The comparative analysis of the strategies "pharma2020" and "Pharma2030" allowed a comprehensive review of the existing system of measures of state support for the development of the pharmaceutical industry, as well as to propose possible measures to improve the system of state support in the provision of subsidies from the Federal budget to reimburse part of the cost of the development and production of domestic drugs - analogues of foreign production within the framework of the policy of import substitution.